Please use this identifier to cite or link to this item: https://saber.ucv.ve/jspui/handle/10872/12119
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDe Sanctis, Juan B.-
dc.contributor.authorZABALETA, MERCEDES-
dc.contributor.authorBianco Colmenares, Nicolás E.-
dc.contributor.authorRIVAS, LILIANA-
dc.contributor.authorGarmendia, Jenny V.-
dc.date.accessioned2015-09-28T22:53:31Z-
dc.date.available2015-09-28T22:53:31Z-
dc.date.issued2009-
dc.identifier.issn0891-6934-
dc.identifier.urihttp://hdl.handle.net/10872/12119-
dc.description.abstractIn patients with systemic lupus erythematosus (SLE) metabolic alterations are often observed, which may be due to either the disease, the genetic background or the treatment. We studied the serum levels of the adipokines leptin, adiponectin, resistin, visfatin and ghrelin in patients with SLE and controls. Leptin levels were lower and adiponectin, ghrelin and visfatin levels were higher in the patients. No significant differences were encountered for resistin. The values of adipokines were independent of treatment, even after correction for body mass index. Inverse correlations were found among leptin and adiponectin, ghrelin and visfatin. We conclude that adipokines are involved in the metabolic imbalance of patients with SLE.es_VE
dc.language.isoenes_VE
dc.publisherAutoimmunityes_VE
dc.relation.ispartofseriesVOL. 42;4-
dc.subjectAdipokineses_VE
dc.subjectleptines_VE
dc.subjectadiponectines_VE
dc.subjectghrelines_VE
dc.subjectresistines_VE
dc.subjectvisfatines_VE
dc.titleSerum adipokine levels in patients with systemic lupus erythematosuses_VE
dc.typeArticlees_VE
Appears in Collections:Artículos Publicados

Files in This Item:
File Description SizeFormat 
Serum adipokine levels in patients with systemic lupus erythematosus.pdf105.66 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.